nodes	percent_of_prediction	percent_of_DWPC	metapath
Xylometazoline—HTR1D—Signaling Pathways—NOTCH2—esophageal cancer	0.000553	0.000553	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—ELMO1—esophageal cancer	0.000547	0.000547	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—CTNNA1—esophageal cancer	0.000543	0.000543	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—SST—esophageal cancer	0.000541	0.000541	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—NOTCH2—esophageal cancer	0.000541	0.000541	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—CXCL2—esophageal cancer	0.00054	0.00054	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—XIAP—esophageal cancer	0.000537	0.000537	CbGpPWpGaD
Xylometazoline—ADRA2A—Hemostasis—CREBBP—esophageal cancer	0.000536	0.000536	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—AKAP13—esophageal cancer	0.000535	0.000535	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000531	0.000531	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—XIAP—esophageal cancer	0.000528	0.000528	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—NOTCH3—esophageal cancer	0.000527	0.000527	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—GHRL—esophageal cancer	0.000527	0.000527	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—PDE4D—esophageal cancer	0.000526	0.000526	CbGpPWpGaD
Xylometazoline—ADRA2A—Platelet activation, signaling and aggregation—PIK3CA—esophageal cancer	0.000524	0.000524	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—ALDH2—esophageal cancer	0.000521	0.000521	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—FBXW7—esophageal cancer	0.000519	0.000519	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—CTNNA1—esophageal cancer	0.000507	0.000507	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—PSME2—esophageal cancer	0.000505	0.000505	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—PSME1—esophageal cancer	0.000505	0.000505	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—CXCL2—esophageal cancer	0.000505	0.000505	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—ANXA1—esophageal cancer	0.000502	0.000502	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—GNG7—esophageal cancer	0.000501	0.000501	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—CTNNA1—esophageal cancer	0.000499	0.000499	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—CXCL2—esophageal cancer	0.000497	0.000497	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—GSTT1—esophageal cancer	0.000496	0.000496	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000493	0.000493	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—TGFBR2—esophageal cancer	0.00049	0.00049	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—CYP2A6—esophageal cancer	0.00049	0.00049	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—PDE4D—esophageal cancer	0.000489	0.000489	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—SST—esophageal cancer	0.000489	0.000489	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—CYP1B1—esophageal cancer	0.000486	0.000486	CbGpPWpGaD
Xylometazoline—ADRA2B—Hemostasis—EP300—esophageal cancer	0.000481	0.000481	CbGpPWpGaD
Xylometazoline—ADRA2A—Hemostasis—NOS3—esophageal cancer	0.00048	0.00048	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—TGFBR2—esophageal cancer	0.00048	0.00048	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—GHRL—esophageal cancer	0.000476	0.000476	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—NOTCH3—esophageal cancer	0.000476	0.000476	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—NOTCH2—esophageal cancer	0.000473	0.000473	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—PSME2—esophageal cancer	0.000471	0.000471	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—PSME1—esophageal cancer	0.000471	0.000471	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—XIAP—esophageal cancer	0.000469	0.000469	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—ANXA1—esophageal cancer	0.000469	0.000469	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—FBXW7—esophageal cancer	0.000468	0.000468	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—GNG7—esophageal cancer	0.000465	0.000465	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—PTGS1—esophageal cancer	0.000465	0.000465	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—ENO1—esophageal cancer	0.000465	0.000465	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—SMAD4—esophageal cancer	0.000464	0.000464	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—PSME2—esophageal cancer	0.000464	0.000464	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—PSME1—esophageal cancer	0.000464	0.000464	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—ANXA1—esophageal cancer	0.000462	0.000462	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—PSME1—esophageal cancer	0.000458	0.000458	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—PSME2—esophageal cancer	0.000458	0.000458	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—CYP19A1—esophageal cancer	0.000457	0.000457	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—SST—esophageal cancer	0.000456	0.000456	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—SMAD4—esophageal cancer	0.000454	0.000454	CbGpPWpGaD
Xylometazoline—ADRA2C—Hemostasis—EP300—esophageal cancer	0.00045	0.00045	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—SST—esophageal cancer	0.000449	0.000449	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—NOTCH3—esophageal cancer	0.000445	0.000445	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—GHRL—esophageal cancer	0.000445	0.000445	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—CTNNA1—esophageal cancer	0.000444	0.000444	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—CXCL2—esophageal cancer	0.000441	0.000441	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—NOTCH3—esophageal cancer	0.000438	0.000438	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—GHRL—esophageal cancer	0.000438	0.000438	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—FBXW7—esophageal cancer	0.000437	0.000437	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—XIAP—esophageal cancer	0.000436	0.000436	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—FBXW7—esophageal cancer	0.000431	0.000431	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—NOTCH2—esophageal cancer	0.000427	0.000427	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—TGFBR2—esophageal cancer	0.00042	0.00042	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—HMOX1—esophageal cancer	0.000417	0.000417	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—CTNNA1—esophageal cancer	0.000412	0.000412	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—PSME2—esophageal cancer	0.000412	0.000412	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—PSME1—esophageal cancer	0.000412	0.000412	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—ANXA1—esophageal cancer	0.00041	0.00041	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—CXCL2—esophageal cancer	0.00041	0.00041	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—ABCB1—esophageal cancer	0.000401	0.000401	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—SST—esophageal cancer	0.000399	0.000399	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—NOTCH2—esophageal cancer	0.000399	0.000399	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—SMAD4—esophageal cancer	0.000397	0.000397	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—CYP1B1—esophageal cancer	0.000395	0.000395	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—NOTCH2—esophageal cancer	0.000393	0.000393	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—GHRL—esophageal cancer	0.000389	0.000389	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—NOTCH3—esophageal cancer	0.000389	0.000389	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—PSME2—esophageal cancer	0.000383	0.000383	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—PSME1—esophageal cancer	0.000383	0.000383	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—FBXW7—esophageal cancer	0.000382	0.000382	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—ANXA1—esophageal cancer	0.000381	0.000381	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—HIF1A—esophageal cancer	0.00038	0.00038	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—TGFBR2—esophageal cancer	0.000379	0.000379	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—HIF1A—esophageal cancer	0.000372	0.000372	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—CYP19A1—esophageal cancer	0.000371	0.000371	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—SST—esophageal cancer	0.000371	0.000371	CbGpPWpGaD
Xylometazoline—ADRA2A—Hemostasis—EP300—esophageal cancer	0.000365	0.000365	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—KDR—esophageal cancer	0.000363	0.000363	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—NOTCH3—esophageal cancer	0.000361	0.000361	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—GHRL—esophageal cancer	0.000361	0.000361	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—SMAD4—esophageal cancer	0.000359	0.000359	CbGpPWpGaD
Xylometazoline—ADRA2B—Hemostasis—PIK3CA—esophageal cancer	0.000356	0.000356	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—KDR—esophageal cancer	0.000356	0.000356	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—FBXW7—esophageal cancer	0.000355	0.000355	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—TGFBR2—esophageal cancer	0.000354	0.000354	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—NOTCH2—esophageal cancer	0.000349	0.000349	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—TGFBR2—esophageal cancer	0.000348	0.000348	CbGpPWpGaD
Xylometazoline—ADRA2B—Hemostasis—TP53—esophageal cancer	0.000345	0.000345	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—NOTCH1—esophageal cancer	0.000342	0.000342	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—HMOX1—esophageal cancer	0.000339	0.000339	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—SMAD4—esophageal cancer	0.000335	0.000335	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—NOTCH1—esophageal cancer	0.000335	0.000335	CbGpPWpGaD
Xylometazoline—ADRA2C—Hemostasis—PIK3CA—esophageal cancer	0.000333	0.000333	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—SMAD4—esophageal cancer	0.00033	0.00033	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—ABCB1—esophageal cancer	0.000325	0.000325	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—HIF1A—esophageal cancer	0.000325	0.000325	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—NOTCH2—esophageal cancer	0.000324	0.000324	CbGpPWpGaD
Xylometazoline—ADRA2C—Hemostasis—TP53—esophageal cancer	0.000322	0.000322	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—KDR—esophageal cancer	0.000311	0.000311	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—CREBBP—esophageal cancer	0.00031	0.00031	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—TGFBR2—esophageal cancer	0.000309	0.000309	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling by GPCR—EGFR—esophageal cancer	0.000305	0.000305	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—CREBBP—esophageal cancer	0.000304	0.000304	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling by GPCR—EGFR—esophageal cancer	0.000298	0.000298	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—HIF1A—esophageal cancer	0.000293	0.000293	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—SMAD4—esophageal cancer	0.000293	0.000293	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—NOTCH1—esophageal cancer	0.000293	0.000293	CbGpPWpGaD
Xylometazoline—HTR1D—GPCR downstream signaling—PIK3CA—esophageal cancer	0.000291	0.000291	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—TGFBR2—esophageal cancer	0.000287	0.000287	CbGpPWpGaD
Xylometazoline—HTR1B—GPCR downstream signaling—PIK3CA—esophageal cancer	0.000285	0.000285	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—KDR—esophageal cancer	0.000281	0.000281	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—NOS3—esophageal cancer	0.000278	0.000278	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—HIF1A—esophageal cancer	0.000274	0.000274	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—SMAD4—esophageal cancer	0.000272	0.000272	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—NOS3—esophageal cancer	0.000272	0.000272	CbGpPWpGaD
Xylometazoline—ADRA2A—Hemostasis—PIK3CA—esophageal cancer	0.00027	0.00027	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—HIF1A—esophageal cancer	0.00027	0.00027	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—CREBBP—esophageal cancer	0.000268	0.000268	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—CREBBP—esophageal cancer	0.000265	0.000265	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling by GPCR—PIK3CA—esophageal cancer	0.000265	0.000265	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—NOTCH1—esophageal cancer	0.000264	0.000264	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—KDR—esophageal cancer	0.000262	0.000262	CbGpPWpGaD
Xylometazoline—ADRA2A—Hemostasis—TP53—esophageal cancer	0.000261	0.000261	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—EGFR—esophageal cancer	0.000261	0.000261	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—ERBB2—esophageal cancer	0.00026	0.00026	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling by GPCR—PIK3CA—esophageal cancer	0.000259	0.000259	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—KDR—esophageal cancer	0.000258	0.000258	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—ERBB2—esophageal cancer	0.000254	0.000254	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCR downstream signaling—PIK3CA—esophageal cancer	0.000249	0.000249	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—NOTCH1—esophageal cancer	0.000247	0.000247	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—NOTCH1—esophageal cancer	0.000243	0.000243	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—NOS3—esophageal cancer	0.00024	0.00024	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—CREBBP—esophageal cancer	0.00024	0.00024	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—HIF1A—esophageal cancer	0.00024	0.00024	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—NOS3—esophageal cancer	0.000238	0.000238	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—EGFR—esophageal cancer	0.000235	0.000235	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—CCND1—esophageal cancer	0.000229	0.000229	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—KDR—esophageal cancer	0.000229	0.000229	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—PIK3CA—esophageal cancer	0.000226	0.000226	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR downstream signaling—PIK3CA—esophageal cancer	0.000225	0.000225	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—CCND1—esophageal cancer	0.000225	0.000225	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—CREBBP—esophageal cancer	0.000224	0.000224	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—HIF1A—esophageal cancer	0.000223	0.000223	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—ERBB2—esophageal cancer	0.000222	0.000222	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—CDKN1A—esophageal cancer	0.000222	0.000222	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—CREBBP—esophageal cancer	0.00022	0.00022	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—EGFR—esophageal cancer	0.00022	0.00022	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—PTGS2—esophageal cancer	0.000219	0.000219	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—CREBBP—esophageal cancer	0.000217	0.000217	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—CDKN1A—esophageal cancer	0.000217	0.000217	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—EGFR—esophageal cancer	0.000216	0.000216	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—NOTCH1—esophageal cancer	0.000216	0.000216	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—NOS3—esophageal cancer	0.000215	0.000215	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—KDR—esophageal cancer	0.000213	0.000213	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—EP300—esophageal cancer	0.000211	0.000211	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR downstream signaling—PIK3CA—esophageal cancer	0.00021	0.00021	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR downstream signaling—PIK3CA—esophageal cancer	0.000207	0.000207	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—EP300—esophageal cancer	0.000207	0.000207	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—PIK3CA—esophageal cancer	0.000204	0.000204	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—ERBB2—esophageal cancer	0.000201	0.000201	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—NOTCH1—esophageal cancer	0.000201	0.000201	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—NOS3—esophageal cancer	0.0002	0.0002	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—NOS3—esophageal cancer	0.000197	0.000197	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—CCND1—esophageal cancer	0.000196	0.000196	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—CREBBP—esophageal cancer	0.000196	0.000196	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—NOS3—esophageal cancer	0.000195	0.000195	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—EGFR—esophageal cancer	0.000192	0.000192	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—PIK3CA—esophageal cancer	0.000191	0.000191	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—CDKN1A—esophageal cancer	0.00019	0.00019	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—PIK3CA—esophageal cancer	0.000188	0.000188	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—ERBB2—esophageal cancer	0.000187	0.000187	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—ERBB2—esophageal cancer	0.000184	0.000184	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—MYC—esophageal cancer	0.000184	0.000184	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR downstream signaling—PIK3CA—esophageal cancer	0.000184	0.000184	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—EP300—esophageal cancer	0.000182	0.000182	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—CREBBP—esophageal cancer	0.000182	0.000182	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—EP300—esophageal cancer	0.000181	0.000181	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—MYC—esophageal cancer	0.00018	0.00018	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—EGFR—esophageal cancer	0.00018	0.00018	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—EGFR—esophageal cancer	0.000179	0.000179	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—PTGS2—esophageal cancer	0.000178	0.000178	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—CCND1—esophageal cancer	0.000177	0.000177	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—EGFR—esophageal cancer	0.000176	0.000176	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—NOS3—esophageal cancer	0.000175	0.000175	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—CDKN1A—esophageal cancer	0.000172	0.000172	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—PIK3CA—esophageal cancer	0.000171	0.000171	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—PIK3CA—esophageal cancer	0.000167	0.000167	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—CCND1—esophageal cancer	0.000166	0.000166	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—ERBB2—esophageal cancer	0.000164	0.000164	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—EP300—esophageal cancer	0.000163	0.000163	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—CCND1—esophageal cancer	0.000163	0.000163	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—NOS3—esophageal cancer	0.000163	0.000163	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—CDKN1A—esophageal cancer	0.00016	0.00016	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—CDKN1A—esophageal cancer	0.000158	0.000158	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—MYC—esophageal cancer	0.000158	0.000158	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—PIK3CA—esophageal cancer	0.000156	0.000156	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—PIK3CA—esophageal cancer	0.000155	0.000155	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—EGFR—esophageal cancer	0.000154	0.000154	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—PIK3CA—esophageal cancer	0.000153	0.000153	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—EP300—esophageal cancer	0.000152	0.000152	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—ERBB2—esophageal cancer	0.000152	0.000152	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—TP53—esophageal cancer	0.000151	0.000151	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—EP300—esophageal cancer	0.00015	0.00015	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—EP300—esophageal cancer	0.000148	0.000148	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—TP53—esophageal cancer	0.000148	0.000148	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—CCND1—esophageal cancer	0.000145	0.000145	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—MYC—esophageal cancer	0.000142	0.000142	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—CDKN1A—esophageal cancer	0.00014	0.00014	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—EGFR—esophageal cancer	0.000139	0.000139	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—PIK3CA—esophageal cancer	0.000135	0.000135	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—CCND1—esophageal cancer	0.000135	0.000135	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—PIK3CA—esophageal cancer	0.000134	0.000134	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—EP300—esophageal cancer	0.000133	0.000133	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—MYC—esophageal cancer	0.000133	0.000133	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—MYC—esophageal cancer	0.000131	0.000131	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—CDKN1A—esophageal cancer	0.00013	0.00013	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—EGFR—esophageal cancer	0.00013	0.00013	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—TP53—esophageal cancer	0.000129	0.000129	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—EGFR—esophageal cancer	0.000128	0.000128	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—EP300—esophageal cancer	0.000124	0.000124	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—PIK3CA—esophageal cancer	0.000121	0.000121	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—TP53—esophageal cancer	0.000117	0.000117	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—MYC—esophageal cancer	0.000116	0.000116	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—EGFR—esophageal cancer	0.000114	0.000114	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—PIK3CA—esophageal cancer	0.000113	0.000113	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—PIK3CA—esophageal cancer	0.000111	0.000111	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—PIK3CA—esophageal cancer	0.00011	0.00011	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—TP53—esophageal cancer	0.000109	0.000109	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—MYC—esophageal cancer	0.000108	0.000108	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—TP53—esophageal cancer	0.000107	0.000107	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—EGFR—esophageal cancer	0.000106	0.000106	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—PIK3CA—esophageal cancer	9.86e-05	9.86e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—TP53—esophageal cancer	9.54e-05	9.54e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—PIK3CA—esophageal cancer	9.16e-05	9.16e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—TP53—esophageal cancer	8.86e-05	8.86e-05	CbGpPWpGaD
